ILC Dover acquires U.K. company
With a customer base across Europe, North America, Asia and Australia, Solo produces flexible film containment isolators, targeting niche applications for pharmaceutical companies. A flexible film containment isolator is a plastic air-tight workspace that prevents the release of highly pathogenic organisms or highly potent compounds.
Solo also pioneered single-use aseptic processing isolators using uni-directional, high-volume airflows. This acquisition will allow ILC Dover to grow its global pharmaceutical and biopharmaceutical business.
“Solo Containment is an innovative company that has pushed the boundaries of containment and is aligned with our commitment to customer-driven, single-use solutions, and the significant value they bring to the industry,” ILC Dover President and CEO Fran DiNuzzo said in a statement.
The acquisition also gives ILC Dover another facility in Europe, with Solo headquartered southeast of Manchester, England. ILC Dover currently operates a production facility in Ireland and a distribution center in Switzerland.
Moving forward, ILC Dover and Solo will also have a combined capability for pharmaceutical and biopharmaceutical manufacturers to further cut costly cleaning processes and reach maximum productivity with a reliable product.
“We have experienced incredible success with single-use solutions for our pharm and biopharma customers, and we’re confident that Solo is the right partner to expand that success,” DiNuzzo added. “We look forward to building on Solo’s track record and reputation of innovation and customer centricity.”
“Partnering with ILC Dover is an exciting step toward continued investment in innovation for Solo,” said Martyn Ryder, the founder of Solo who will remain with the company. “ILC Dover shares our vision of the future of flexible containment, and we look forward to delivering best-in-class performance and tremendous product value to our global customer base.”
This is the first acquisition that ILC Dover has completed since it was acquired by New York-based investment firm New Mountain Capital in February.
By Katie Tabeling